Strength
60 mg/1
Manufacturer
AvPAKNDC
50268081312
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ZIPRASIDONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077561On Market Since
5/12/2021
Pharmacological Classes
Price Statistics
The NADAC for ZIPRASIDONE HCL 60 MG CAPSULE has been published 250 times since Sep 15, 2021, and over the history we have for it it has declined 13.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3290 per EA |
|---|---|
| All-time high | $0.4208 (Feb 16, 2022) |
| All-time low | $0.2545 (Nov 20, 2024) |
| 52-week high | $0.3372 |
| 52-week low | $0.3159 |
| Median price | $0.3504 |
| Average price | $0.3443 |
| Largest weekly change | +29.3% (Aug 21, 2024) |
| Weeks tracked | 250 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZIPRASIDONE HCL 60 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ZIPRASIDONE HCL 60 MG CAPSULE, manufactured by AvPAK, is $0.3290 per EA (NDC 50268081312), effective Jun 24, 2026.
How has the price of ZIPRASIDONE HCL 60 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ZIPRASIDONE HCL 60 MG CAPSULE has declined 13.3%. It has been tracked across 250 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for ZIPRASIDONE HCL 60 MG CAPSULE?
Since Sep 15, 2021, the NADAC for ZIPRASIDONE HCL 60 MG CAPSULE has ranged from a low of $0.2545 (Nov 20, 2024) to a high of $0.4208 (Feb 16, 2022), with a median of $0.3504 per EA.
Are there cheaper alternatives to ZIPRASIDONE HCL 60 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ZIPRASIDONE HCL 60 MG CAPSULE, but none are currently priced below it.
Who manufactures ZIPRASIDONE HCL 60 MG CAPSULE?
ZIPRASIDONE HCL 60 MG CAPSULE (NDC 50268081312) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification